The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Infertility-Global Market Insights and Sales Trends 2024
Synopsis
In humans, infertility is the inability to become pregnant or carry a pregnancy to full term. There are many causes of infertility, including some that medical intervention can treat.
The global Infertility market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Infertility in various end use industries. The expanding demands from the Male and Female, are propelling Infertility market. Assisted Reproductive Technology (ART), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Artificial Insemination segment is estimated at % CAGR for the next seven-year period.
Estimates from 1997 suggest that worldwide about five percent of all heterosexual couples have an unresolved problem with infertility. Many more couples, however, experience involuntary childlessness for at least one year: estimates range from 12% to 28%. 20-30% of infertility cases are due to male infertility, 20-35% are due to female infertility, and 25-40% are due to combined problems in both parts. In 10-20% of cases, no cause is found.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Infertility, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Infertility market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Infertility market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Infertility sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Infertility covered in this report include The Cooper Companies, Cook Group, Thermo Fisher Scientific, Vitrolife, Esco Micro, Genea, Irvine Scientific, Ivftech and The Baker Company, etc.
The global Infertility market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
The Cooper Companies
Cook Group
Thermo Fisher Scientific
Vitrolife
Esco Micro
Genea
Irvine Scientific
Ivftech
The Baker Company
Kitazato
Rinovum Women’s Health
Rocket Medical
Ihmedical
Global Infertility market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Infertility market, Segment by Type:
Assisted Reproductive Technology (ART)
Artificial Insemination
Fertility Surgeries
Global Infertility market, by Application
Male
Female
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Infertility companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
In humans, infertility is the inability to become pregnant or carry a pregnancy to full term. There are many causes of infertility, including some that medical intervention can treat.
The global Infertility market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Infertility in various end use industries. The expanding demands from the Male and Female, are propelling Infertility market. Assisted Reproductive Technology (ART), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Artificial Insemination segment is estimated at % CAGR for the next seven-year period.
Estimates from 1997 suggest that worldwide about five percent of all heterosexual couples have an unresolved problem with infertility. Many more couples, however, experience involuntary childlessness for at least one year: estimates range from 12% to 28%. 20-30% of infertility cases are due to male infertility, 20-35% are due to female infertility, and 25-40% are due to combined problems in both parts. In 10-20% of cases, no cause is found.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Infertility, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Infertility market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Infertility market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Infertility sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Infertility covered in this report include The Cooper Companies, Cook Group, Thermo Fisher Scientific, Vitrolife, Esco Micro, Genea, Irvine Scientific, Ivftech and The Baker Company, etc.
The global Infertility market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
The Cooper Companies
Cook Group
Thermo Fisher Scientific
Vitrolife
Esco Micro
Genea
Irvine Scientific
Ivftech
The Baker Company
Kitazato
Rinovum Women’s Health
Rocket Medical
Ihmedical
Global Infertility market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Infertility market, Segment by Type:
Assisted Reproductive Technology (ART)
Artificial Insemination
Fertility Surgeries
Global Infertility market, by Application
Male
Female
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Infertility companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Infertility
1.1 Infertility Market Overview
1.1.1 Infertility Product Scope
1.1.2 Infertility Market Status and Outlook
1.2 Global Infertility Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Infertility Market Size by Region (2018-2029)
1.4 Global Infertility Historic Market Size by Region (2018-2023)
1.5 Global Infertility Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Infertility Market Size (2018-2029)
1.6.1 North America Infertility Market Size (2018-2029)
1.6.2 Europe Infertility Market Size (2018-2029)
1.6.3 Asia-Pacific Infertility Market Size (2018-2029)
1.6.4 Latin America Infertility Market Size (2018-2029)
1.6.5 Middle East & Africa Infertility Market Size (2018-2029)
2 Infertility Market by Type
2.1 Introduction
2.1.1 Assisted Reproductive Technology (ART)
2.1.2 Artificial Insemination
2.1.3 Fertility Surgeries
2.2 Global Infertility Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Infertility Historic Market Size by Type (2018-2023)
2.2.2 Global Infertility Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Infertility Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Infertility Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Infertility Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Infertility Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Infertility Revenue Breakdown by Type (2018-2029)
3 Infertility Market Overview by Application
3.1 Introduction
3.1.1 Male
3.1.2 Female
3.2 Global Infertility Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Infertility Historic Market Size by Application (2018-2023)
3.2.2 Global Infertility Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Infertility Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Infertility Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Infertility Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Infertility Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Infertility Revenue Breakdown by Application (2018-2029)
4 Infertility Competition Analysis by Players
4.1 Global Infertility Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Infertility as of 2022)
4.3 Date of Key Players Enter into Infertility Market
4.4 Global Top Players Infertility Headquarters and Area Served
4.5 Key Players Infertility Product Solution and Service
4.6 Competitive Status
4.6.1 Infertility Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 The Cooper Companies
5.1.1 The Cooper Companies Profile
5.1.2 The Cooper Companies Main Business
5.1.3 The Cooper Companies Infertility Products, Services and Solutions
5.1.4 The Cooper Companies Infertility Revenue (US$ Million) & (2018-2023)
5.1.5 The Cooper Companies Recent Developments
5.2 Cook Group
5.2.1 Cook Group Profile
5.2.2 Cook Group Main Business
5.2.3 Cook Group Infertility Products, Services and Solutions
5.2.4 Cook Group Infertility Revenue (US$ Million) & (2018-2023)
5.2.5 Cook Group Recent Developments
5.3 Thermo Fisher Scientific
5.3.1 Thermo Fisher Scientific Profile
5.3.2 Thermo Fisher Scientific Main Business
5.3.3 Thermo Fisher Scientific Infertility Products, Services and Solutions
5.3.4 Thermo Fisher Scientific Infertility Revenue (US$ Million) & (2018-2023)
5.3.5 Vitrolife Recent Developments
5.4 Vitrolife
5.4.1 Vitrolife Profile
5.4.2 Vitrolife Main Business
5.4.3 Vitrolife Infertility Products, Services and Solutions
5.4.4 Vitrolife Infertility Revenue (US$ Million) & (2018-2023)
5.4.5 Vitrolife Recent Developments
5.5 Esco Micro
5.5.1 Esco Micro Profile
5.5.2 Esco Micro Main Business
5.5.3 Esco Micro Infertility Products, Services and Solutions
5.5.4 Esco Micro Infertility Revenue (US$ Million) & (2018-2023)
5.5.5 Esco Micro Recent Developments
5.6 Genea
5.6.1 Genea Profile
5.6.2 Genea Main Business
5.6.3 Genea Infertility Products, Services and Solutions
5.6.4 Genea Infertility Revenue (US$ Million) & (2018-2023)
5.6.5 Genea Recent Developments
5.7 Irvine Scientific
5.7.1 Irvine Scientific Profile
5.7.2 Irvine Scientific Main Business
5.7.3 Irvine Scientific Infertility Products, Services and Solutions
5.7.4 Irvine Scientific Infertility Revenue (US$ Million) & (2018-2023)
5.7.5 Irvine Scientific Recent Developments
5.8 Ivftech
5.8.1 Ivftech Profile
5.8.2 Ivftech Main Business
5.8.3 Ivftech Infertility Products, Services and Solutions
5.8.4 Ivftech Infertility Revenue (US$ Million) & (2018-2023)
5.8.5 Ivftech Recent Developments
5.9 The Baker Company
5.9.1 The Baker Company Profile
5.9.2 The Baker Company Main Business
5.9.3 The Baker Company Infertility Products, Services and Solutions
5.9.4 The Baker Company Infertility Revenue (US$ Million) & (2018-2023)
5.9.5 The Baker Company Recent Developments
5.10 Kitazato
5.10.1 Kitazato Profile
5.10.2 Kitazato Main Business
5.10.3 Kitazato Infertility Products, Services and Solutions
5.10.4 Kitazato Infertility Revenue (US$ Million) & (2018-2023)
5.10.5 Kitazato Recent Developments
5.11 Rinovum Women’s Health
5.11.1 Rinovum Women’s Health Profile
5.11.2 Rinovum Women’s Health Main Business
5.11.3 Rinovum Women’s Health Infertility Products, Services and Solutions
5.11.4 Rinovum Women’s Health Infertility Revenue (US$ Million) & (2018-2023)
5.11.5 Rinovum Women’s Health Recent Developments
5.12 Rocket Medical
5.12.1 Rocket Medical Profile
5.12.2 Rocket Medical Main Business
5.12.3 Rocket Medical Infertility Products, Services and Solutions
5.12.4 Rocket Medical Infertility Revenue (US$ Million) & (2018-2023)
5.12.5 Rocket Medical Recent Developments
5.13 Ihmedical
5.13.1 Ihmedical Profile
5.13.2 Ihmedical Main Business
5.13.3 Ihmedical Infertility Products, Services and Solutions
5.13.4 Ihmedical Infertility Revenue (US$ Million) & (2018-2023)
5.13.5 Ihmedical Recent Developments
6 North America
6.1 North America Infertility Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Infertility Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Infertility Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Infertility Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Infertility Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Infertility Market Dynamics
11.1 Infertility Industry Trends
11.2 Infertility Market Drivers
11.3 Infertility Market Challenges
11.4 Infertility Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
